Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Prenetics Global Limited - Class A Ordinary Share (NQ:PRE)

19.32 +0.50 (+2.63%)
Streaming Delayed Price Updated: 9:45 AM EDT, Jun 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,764
Open 18.59
Bid (Size) 18.65 (500)
Ask (Size) 20.00 (500)
Prev. Close 18.83
Today's Range 18.21 - 19.32
52wk Range 7.175 - 23.63
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Appoints Hudson Leogrande, Founder and CEO of Multi-Billion-Dollar DTC Brand Comfrt, to Board of Directors as IM8 Accelerates TikTok and Meta Expansion
From Prenetics Global Limited
Via GlobeNewswire

Performance

YTD
+22.5%
+22.5%
1 Month
-8.4%
-8.4%
3 Month
-3.1%
-3.1%
6 Month
+18.7%
+18.7%
1 Year
+127.0%
+127.0%

More News

Read More
News headline image
Prenetics Announces Jay Shetty as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
From Prenetics Global Limited
Via GlobeNewswire
Prenetics Global Ltd. (NASDAQ:PRE) Reports Q4 Revenue Beat and Narrower Loss on IM8 Strength ↗
Via Chartmill
News headline image
Prenetics (PRE) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Prenetics Global Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Prenetics Welcomes Brian J. Rosin as Chief Financial Officer of IM8
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Announces Preliminary Record Q1 2026 Results with IM8 Revenue Growing Nearly 6x YoY; Company Raises Full-Year 2026 IM8 Revenue Guidance to $190M–$210M
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics’ IM8 Health Partners with Vitamin Angels to Combat Global Malnutrition, Commits to Impacting 400,000 Mothers and Children in Year One
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Announces NBA Champion and Two-Time MVP Giannis Antetokounmpo as IM8 Global Partner and Shareholder in Multi-Year Partnership
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics to Participate in the 38th Annual ROTH Conference
From Prenetics Global Limited
Via GlobeNewswire
The market is filled with gapping stocks in Friday's session. ↗
Via Chartmill
News headline image
Prenetics Authorizes $40 Million Share Repurchase Program
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Executives Execute Second Consecutive Round of Post-Earnings Open Market Share Purchases of $1.3 Million— Cumulative Personal Investment Across Both Rounds Reaches $2.7 Million
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Launches IM8 Daily Ultimate Essentials PRO — A Clinical Formula with Two New Flavours
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Appoints Renowned Longevity Expert and Health-Tech CEO, Dr. Darshan Shah, to Board of Directors
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Completes $70 Million Insighta Sale to Tencent, Bolstering Balance Sheet to $171.1 Million in Total Adjusted Liquidity
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Formula 1 Phenom Ollie Bearman Joins Prenetics’ IM8 Health as Global Ambassador and Shareholder
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics to Report Q4 and Full Year 2025 Financial Results on Feb 18, 2026 and Host Earnings Conference Call
From Prenetics Global Limited
Via GlobeNewswire
News headline image
Prenetics Reinforces Strategic Focus on IM8, Divests Europa Business For Up to $13 Million
From Prenetics Global Limited
Via GlobeNewswire

Frequently Asked Questions

Is Prenetics Global Limited - Class A Ordinary Share publicly traded?
Yes, Prenetics Global Limited - Class A Ordinary Share is publicly traded.
What exchange does Prenetics Global Limited - Class A Ordinary Share trade on?
Prenetics Global Limited - Class A Ordinary Share trades on the Nasdaq Stock Market
What is the ticker symbol for Prenetics Global Limited - Class A Ordinary Share?
The ticker symbol for Prenetics Global Limited - Class A Ordinary Share is PRE on the Nasdaq Stock Market
What is the current price of Prenetics Global Limited - Class A Ordinary Share?
The current price of Prenetics Global Limited - Class A Ordinary Share is 19.32
When was Prenetics Global Limited - Class A Ordinary Share last traded?
The last trade of Prenetics Global Limited - Class A Ordinary Share was at 06/29/26 09:45 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.